Delving into the Latest Updates on Hunan Sailong Pharmaceutical (Changsha) Co., Ltd. with Synapse

Overview

考察健康受试者在空腹条件下，单次注射由湖南赛隆药业有限公司生产的注射用伏立康唑（受试制剂T，规格：200mg）与单次注射由Pfizer Europe MA EEIG持证的注射用伏立康唑（参比制剂R，商品名：Vfend®，规格：200mg）的药动学特征，评价两制剂的生物等效性和安全性，为该受试制剂注册申请提供依据。

[Translation]

To investigate the pharmacokinetic characteristics of a single injection of voriconazole for injection (test preparation T, strength: 200 mg) produced by Hunan Sailon Pharmaceutical Co., Ltd. and a single injection of voriconazole for injection certified by Pfizer Europe MA EEIG (reference preparation R, trade name: Vfend®, strength: 200 mg) in healthy subjects under fasting conditions, evaluate the bioequivalence and safety of the two preparations, and provide a basis for the registration application of the test preparation.

Start Date02 Aug 2023

Sponsor / Collaborator

Hunan Sailong Pharmaceutical (Changsha) Co., Ltd.

100 Clinical Results associated with Hunan Sailong Pharmaceutical (Changsha) Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Hunan Sailong Pharmaceutical (Changsha) Co., Ltd.

Login to view more data

100 Deals associated with Hunan Sailong Pharmaceutical (Changsha) Co., Ltd.

Login to view more data

100 Translational Medicine associated with Hunan Sailong Pharmaceutical (Changsha) Co., Ltd.

Login to view more data